Answers are grounded in this paper and cite their sources.
NIR absorbing squaraine dyes SQ1 – SQ7 having 1 H -benzo[ c, d ]indol-2-ylidene as a donor moiety were designed for application in DSSCs. Annulation of the benzene ring to an 3 H -indolium-based anchor moiety led to a red-shifted and broadened absorption band on TiO 2 film, which were reflected in the improved short-circuit current density of SQ2 (6.22 mA cm –2 ) compared to the nonbenzene fused derivative SQ1 (4.39 mA cm –2 ). Although the introduction of a butoxy ( SQ4: 806 nm) or dialkylamino group ( SQ5 – SQ7: 815–820 nm) to the 1 H -benzo[ c, d ]indol-2-ylidene-based donor moiety resulted in red-shifted absorption maxima in ethanol compared to the nonsubstituted derivative SQ2 (784 nm), the HOMO energy level of SQ4 – SQ7 gave rise to an undesirable approximation to the redox potential of I – /I 3 – . Thus, the butoxy ( SQ4: 0.56) and dialkylamino ( SQ5 – SQ7: 0.25–0.30) derivatives had relatively lower conversion efficiencies. Since the 2-ethylhexyl derivative SQ3 exhibited red-shifted absorption (λ max: 796 nm), suitable HOMO and LUMO energy levels, and relatively efficient restriction of charge recombination, this dye achieved the highest conversion efficiency (1.31%), along with a high IPCE response of over 20% over a wide range from 640 to 860 nm and an onset of IPCE at 1000 nm.
No takes yet. Share an insight, caveat, or question.
Haishima et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: